Literature DB >> 10195875

Effect of dialysis membranes on lipoprotein profile of serum in haemodialysed patients.

E Kimak1, J Solski, L Janicka, B Wojtysiak, M Zagojska.   

Abstract

The subjects of the studies were 31 haemodialysed (HD) patients with chronic renal insufficiency (CRI). In this group of patients the lipoprotein profile was determined and 8 patients were selected for further studies. During the study the patients were treated with cuprophane membranes for 6 months. For the next 6 months the same patients were treated using polysulfone dialysers, and for further 6 months HD with polysulfone dialysers was continued. Patients' sera were tested after every 6 months of treatment. The delta values were calculated as 6-month HD with polysulfone minus 6-month HD with cuprophane (deltaI) and 12-month HD with polysulfone minus 6-month HD with polysulfone (deltaII). We concluded that after long-term HD with low flux polysulfone treatment the lipoprotein profiles improved, but the mechanism of the process is not clear.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10195875     DOI： 10.1007/bf02564868

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  20 in total

Review 1.  Lipid abnormalities in renal disease.

Authors:  G Appel
Journal:  Kidney Int       Date:  1991-01       Impact factor: 10.612

2.  Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure.

Authors:  M Akmal; S E Kasim; A R Soliman; S G Massry
Journal:  Kidney Int       Date:  1990-03       Impact factor: 10.612

3.  Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B.

Authors:  A Chait; R L Brazg; D L Tribble; R M Krauss
Journal:  Am J Med       Date:  1993-04       Impact factor: 4.965

Review 4.  Hemodialysis using high flux membranes improves lipid profiles.

Authors:  P J Blankestijn
Journal:  Clin Nephrol       Date:  1994-07       Impact factor: 0.975

5.  Plasma lipoproteins in patients with chronic renal failure (CRF).

Authors:  E Kimak; J Solski; L Janicka; D Duma; M Zagojska
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

6.  High flux dialysis membranes improve plasma lipoprotein profiles in patients with end-stage renal disease.

Authors:  I J Goldberg; A M Kaufman; V A Lavarias; T Vanni-Reyes; N W Levin
Journal:  Nephrol Dial Transplant       Date:  1996       Impact factor: 5.992

7.  Improvement of plasma lipoprotein profiles during high-flux dialysis.

Authors:  D S Seres; G W Strain; S A Hashim; I J Goldberg; N W Levin
Journal:  J Am Soc Nephrol       Date:  1993-01       Impact factor: 10.121

8.  Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia.

Authors:  T Murase; D C Cattran; B Rubenstein; G Steiner
Journal:  Metabolism       Date:  1975-11       Impact factor: 8.694

9.  Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis.

Authors:  D O'Neal; P Lee; B Murphy; J Best
Journal:  Am J Kidney Dis       Date:  1996-01       Impact factor: 8.860

10.  High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients.

Authors:  P J Blankestijn; P F Vos; T J Rabelink; H J van Rijn; H Jansen; H A Koomans
Journal:  J Am Soc Nephrol       Date:  1995-03       Impact factor: 10.121
View more
  1 in total

1.  Lipid and lipoprotein ratios as risk factors of atherosclerosis in patients with chronic renal insufficiency (CRI).

Authors:  E Kimak; J Solski; L Janicka; M Zagojska
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.